Today, the FDA issued an emergency use authorization for two monoclonal antibodies administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients who are at high risk for progressing to severe COVID-19.
Copyright © 2024 | WordPress Theme by MH Themes